DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Gimoti is a drug marketed by Evoke Pharma Inc and is included in one NDA. There are two patents protecting this drug.
This drug has nineteen patent family members in twelve countries.
The generic ingredient in GIMOTI is metoclopramide hydrochloride. There are fourteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.
A generic version of GIMOTI was approved as metoclopramide hydrochloride by TEVA on July 29th, 1985.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Evoke Pharma Inc||GIMOTI||metoclopramide hydrochloride||SPRAY, METERED;NASAL||209388-001||Jun 19, 2020||RX||Yes||Yes||Start Trial||Start Trial||Y||Start Trial|
|Evoke Pharma Inc||GIMOTI||metoclopramide hydrochloride||SPRAY, METERED;NASAL||209388-001||Jun 19, 2020||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|